Exclusive: Pfizer says will continue to engage with govt to make its COVID-19 vaccine available in India

In February, had the firm withdrawn an application for emergency-use authorisation of its vaccine in India, after failing to meet the drug regulator’s demand for a local safety and immunogenicity study. Now, as per a new rule, the company is eligible to directly seek EUA from the Drugs Controller General of India.

from Moneycontrol Business News https://ift.tt/3gpjbC7